Profile of Attendance
Over 350 delegates are expected to attend Pancreas 2016. The previous conference in Verona attracted this number and the very strong scientific and educational programme, combined with the attractiveness and accessibility of Glasgow as a destination, leads us to be confident of an excellent attendance at the 2016 Conference.
This biennial conference provides an international forum for clinicians, surgeons and other specialists such as medical oncologists, imaging radiographers, oncology radiographers, gastro-enterologists, molecular pathologists and clinical scientists involved in the treatment of pancreatic cancer and as the conference has a translational theme we will also be actively encouraging pathologists and basic scientists to attend.
The treatment of pancreatic cancer requires close co-operation between specialists from different medical disciplines as well as those involved in research into the disease, so while the majority of delegates will be specialist clinicians and surgeons, the support of an interdisciplinary approach towards research, treatment and care will be one of the key objectives of Pancreas 2016, and the conference will provide a critical mass of delegates to explore developing challenges and areas of debate in pancreatic cancer.
The previous conferences in Verona (2014) and Kyoto (2016) were very well-attended with representation across a broad spectrum of the international pancreatic cancer community. Based on the delegate profiles from previous meetings, we expect that approximately 35% of participants will be from the UK, 30% from elsewhere in Europe, 20% from North America, 8% from Australia and New Zealand, with the remaining 7% from the rest of the world.
Anticipated Attendance by Region
The International Symposium on Pancreatic Cancer, “Pancreas 2016” will take place in the historic Bute Hall at the University of Glasgow, UK. To read more regarding the venue please click here.